1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Advanced Tumors: new trials by email Literature Review of Advanced Tumors trials Research Report on Advanced Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms Tarlatamab treatment - DLL3-expressing Tumors, Advanced Tumors | Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 29 | 2025-03-21 | 2026-09-01 |
Neoplasms (1)
Jonsson Comprehensive Cancer Center (1)
United States (1)